Two Sigma Advisers’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$15.1K Sell
2025
Q1
$77.8K Buy
2024
Q4
$103K Sell
2024
Q3
$786K Sell
2024
Q2
$878K Sell
2024
Q1
$1.52M Sell
2023
Q4
$1.36M Buy
2023
Q3
$493K Sell
2023
Q2
$604K Sell
2023
Q1
$808K Buy
2022
Q4
$1.13M Buy
2022
Q3
$796K Buy